Overview

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

Status:
Completed
Trial end date:
2020-11-06
Target enrollment:
Participant gender:
Summary
This Phase 1 study will assess the pharmacokinetic effect of multiple doses PF 06700841 (administered once a day) on a single dose of a combination oral contraceptive, in 18 healthy female participants who are not of childbearing potential.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Contraceptive Agents
Contraceptives, Oral
Estradiol
Ethinyl Estradiol
Levonorgestrel
PF-06700841